| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76045-114-10 | 76045-114 | HUMAN PRESCRIPTION DRUG | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | INJECTION, SOLUTION | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS | 20240402 | N/A | ANDA | ANDA213573 | Fresenius Kabi USA, LLC | NALOXONE HYDROCHLORIDE | .4 mg/mL | 24 SYRINGE in 1 CARTON (76045-114-10) / 1 mL in 1 SYRINGE (76045-114-01) |
| 76045-112-20 | 76045-112 | HUMAN PRESCRIPTION DRUG | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | INJECTION, SOLUTION | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS | 20240402 | N/A | ANDA | ANDA213573 | Fresenius Kabi USA, LLC | NALOXONE HYDROCHLORIDE | 1 mg/mL | 24 SYRINGE in 1 CASE (76045-112-20) / 2 mL in 1 SYRINGE (76045-112-01) |